Related Articles
PHARMACOKINETICS OF CARBOPLATIN IN A PATIENT WITH BOTH TESTICULAR CANCER AND HEMODIALYSIS-REQUIRING KIDNEY FAILURE
Evaluation of serum iron levels during FOLFOX4 and FOLFIRI therapies
Mechanism underlying the transient increase of serum iron during FOLFOX/FOLFIRI therapy
Assessment of the efficacy of two dosages and schedules of human recombinant erythropoietin in the prevention and correction of cisplatin-induced anemia in cancer patients.
A multivariate analysis for predicting cisplatin-induced delayed emesis.